Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)
Phongthon Kanjanasirirat, Kedchin Jearawuttanakul, Sawinee Seemakhan, Suparerk Borwornpinyo, Patompon Wongtrakoongate, Suradej Hongeng, Sitthivut Charoensutthivarakul
TL;DR
This paper corrects a previous study that found colchicine, an FDA-approved drug, may be effective against a rare type of childhood brain tumor.
Contribution
The correction addresses errors in the original study's findings and data presentation.
Findings
The original study's data on colchicine's effectiveness against AT/RTs was corrected.
The revised analysis confirms the need for further validation of the drug's therapeutic potential.
Abstract
Correction for ‘High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)’ by Phongthon Kanjanasirirat et al., RSC Adv., 2025, 15, 12331–12341, https://doi.org/10.1039/D5RA01341K.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —Ramathibodi Foundation10.13039/501100019274
- —Thailand Center of Excellence for Life Sciences10.13039/100015396
- —Faculty of Science, Mahidol University10.13039/501100007180
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChromatin Remodeling and Cancer · Retinoids in leukemia and cellular processes · Protein Degradation and Inhibitors
The authors regret the omission of Tanawadee Khumpanied from the Acknowledgements. The correct Acknowledgements are as shown here.
This research was partially supported by the Ramathibodi Foundation and Thailand Center of Excellence for Life Sciences (TCELS), and also by the Faculty of Science, Mahidol University via the Reinventing University Project. The authors would like to thank Dr Witchuda Saengsawang, Dr Jiraporn Panmanee and Dr Sujira Mukda for discussions and Ms Tanawadee Khumpanied for preliminary data collection.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.